{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:12Z","timestamp":1792839612344,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>We evaluated trends and outcomes of liver transplantation (LT) recipients with\/without HIV infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>LT recipients between 2008 and 2015 from the United Network for Organ Sharing and Organ Procurement and Transplantation Network and European Liver Transplant Registry were included. Trends and characteristics related to survival among LT recipients with HIV infection were determined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Among 73\u2009206 LT patients, 658 (0.9%) were HIV-infected. The proportion of LT HIV-infected did not change over time (<jats:italic toggle=\"yes\">P<\/jats:italic>-trend = 0.16). Hepatitis C virus (HCV) as indication for LT decreased significantly for HIV-infected and HIV-uninfected patients (<jats:italic toggle=\"yes\">P<\/jats:italic>-trends = 0.008 and &lt;0.001). Three-year cumulative graft survival in LT recipients with and without HIV infection was 64.4% and 77.3%, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), with improvements over time for both, but with HIV-infected patients having greater improvements (<jats:italic toggle=\"yes\">P<\/jats:italic>-trends = 0.02 and 0.03). Adjusted risk of graft loss was 41% higher in HIV-infected versus HIV-uninfected (adjusted hazard ratio [aHR], 1.41; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Among HIV-infected, model of end-stage liver disease (aHR, 1.04; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), body mass index &lt;21\u2009kg\/m<jats:sup>2<\/jats:sup> (aHR, 1.61; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.006), and HCV (aHR, 1.83; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) were associated with graft loss, whereas more recent period of LT 2012\u20132015 (aHR, 0.58; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001) and donor with anoxic cause of death (aHR, 0.51; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.007) were associated with lower risk of graft loss.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Patients with HIV infection account for only 1% of LTs in United States and Europe, with fewer LT for HCV disease over time. A static rate of LT among HIV-infected patients may reflect improvements in cirrhosis management and\/or persistent barriers to LT. Graft and patient survival among HIV-infected LT recipients have shown improvement over time.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003107","type":"journal-article","created":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T21:05:05Z","timestamp":1577912705000},"page":"2078-2086","source":"Crossref","is-referenced-by-count":35,"title":["Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States"],"prefix":"10.1097","volume":"104","author":[{"given":"Isabel","family":"Campos-Varela","sequence":"first","affiliation":[{"name":"Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d\u2019Hebron, Vall d\u2019Hebron Institut de Recerca, Barcelona, Spain."},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Dodge","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California\u2013San Francisco, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Berenguer","sequence":"additional","affiliation":[{"name":"Liver Unit, La Fe University Hospital, Ciberehd, IISLaFe, University of Medicine, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Adam","sequence":"additional","affiliation":[{"name":"Centre H\u00e9pato-Biliaire, AP-HP H\u00f4pital Paul Brousse, University Paris Sud Villejuif, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Samuel","sequence":"additional","affiliation":[{"name":"Centre H\u00e9pato-Biliaire, AP-HP H\u00f4pital Paul Brousse, University Paris Sud Villejuif, Paris, France."},{"name":"University Paris Sud-Paris Saclay, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Di Benedetto","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Karam","sequence":"additional","affiliation":[{"name":"Centre H\u00e9pato-Biliaire, AP-HP H\u00f4pital Paul Brousse, University Paris Sud Villejuif, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca S.","family":"Belli","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Niguarda Hospital, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Duvoux","sequence":"additional","affiliation":[{"name":"Department of Hepatology, University Hospital of Henri Mondor-APHP, Paris Est University (UPEC), Cr\u00e9teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah A.","family":"Terrault","sequence":"additional","affiliation":[{"name":"Keck School of Medicine, University of Southern California, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hep.25800","article-title":"The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection.","volume":"57","author":"Ioannou","year":"2013","journal-title":"Hepatology"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1468-1293.2012.01051.x","article-title":"Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.","volume":"14","author":"Weber","year":"2013","journal-title":"HIV Med"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/0956462416632428","article-title":"Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis.","volume":"28","author":"Farahani","year":"2017","journal-title":"Int J STD AIDS"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/lt.23411","article-title":"Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.","volume":"18","author":"Terrault","year":"2012","journal-title":"Liver Transpl"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1600-6143.2012.04028.x","article-title":"Outcome of HCV\/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study.","volume":"12","author":"Miro","year":"2012","journal-title":"Am J Transplant"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.21990","article-title":"Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.","volume":"47","author":"Duclos-Vall\u00e9e","year":"2008","journal-title":"Hepatology"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/cid\/civ471","article-title":"Beyond the NIH multicenter HIV transplant trial experience: outcomes of HIV+ liver transplant recipients compared to HCV+ or HIV+\/HCV+ coinfected recipients in the United States.","volume":"61","author":"Sawinski","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/apt.13629","article-title":"Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.","volume":"43","author":"Campos-Varela","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11904-013-0170-z","article-title":"Solid organ transplants in HIV-infected patients.","volume":"10","author":"Harbell","year":"2013","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies.","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2017.03.011","article-title":"Global trends and predictions in hepatocellular carcinoma mortality.","volume":"67","author":"Bertuccio","year":"2017","journal-title":"J Hepatol"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/bdd.1860","article-title":"Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients.","volume":"34","author":"Frassetto","year":"2013","journal-title":"Biopharm Drug Dispos"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/cid\/ciu515","article-title":"Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.","volume":"59","author":"Barau","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/cid\/ciu731","article-title":"Advances in therapy for HIV\/hepatitis C virus-coinfected patients in the liver transplant setting.","volume":"60","author":"Campos-Varela","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/lt.24027","article-title":"Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus\/hepatitis C virus-coinfected liver transplant recipients.","volume":"21","author":"Campos-Varela","year":"2015","journal-title":"Liver Transpl"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/lt.23970","article-title":"Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation.","volume":"20","author":"Hamaguchi","year":"2014","journal-title":"Liver Transpl"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/ajt.12762","article-title":"Frailty predicts waitlist mortality in liver transplant candidates.","volume":"14","author":"Lai","year":"2014","journal-title":"Am J Transplant"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/cid\/ciy1082","article-title":"Liver-related events in human immunodeficiency virus-infected persons with occult cirrhosis.","volume":"69","author":"Benmassaoud","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"ofz124","DOI":"10.1093\/ofid\/ofz124","article-title":"Trends in comorbid conditions among Medicaid enrollees with HIV.","volume":"6","author":"Cole","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/cid\/ciw380","article-title":"Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus-coinfected individuals from 2001 to 2014: a multicohort study.","volume":"63","author":"Gjaerde","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/jvh.13146","article-title":"Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B\/C virus co-infected HIV patients with cirrhosis.","volume":"26","author":"Willemse","year":"2019","journal-title":"J Viral Hepat"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:47:27Z","timestamp":1696225647000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003107","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,31]]}}}